nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoteridol—Loss of consciousness—Efavirenz—acquired immunodeficiency syndrome	0.0019	0.0019	CcSEcCtD
Gadoteridol—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.00189	0.00189	CcSEcCtD
Gadoteridol—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.00189	0.00189	CcSEcCtD
Gadoteridol—Cough—Efavirenz—acquired immunodeficiency syndrome	0.00189	0.00189	CcSEcCtD
Gadoteridol—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.00188	0.00188	CcSEcCtD
Gadoteridol—Feeling abnormal—Abacavir—acquired immunodeficiency syndrome	0.00188	0.00188	CcSEcCtD
Gadoteridol—Dysgeusia—Ritonavir—acquired immunodeficiency syndrome	0.00187	0.00187	CcSEcCtD
Gadoteridol—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.00187	0.00187	CcSEcCtD
Gadoteridol—Oedema—Indinavir—acquired immunodeficiency syndrome	0.00187	0.00187	CcSEcCtD
Gadoteridol—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.00187	0.00187	CcSEcCtD
Gadoteridol—Hypertension—Efavirenz—acquired immunodeficiency syndrome	0.00187	0.00187	CcSEcCtD
Gadoteridol—Malaise—Delavirdine—acquired immunodeficiency syndrome	0.00186	0.00186	CcSEcCtD
Gadoteridol—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.00186	0.00186	CcSEcCtD
Gadoteridol—Syncope—Delavirdine—acquired immunodeficiency syndrome	0.00185	0.00185	CcSEcCtD
Gadoteridol—Erythema—Saquinavir—acquired immunodeficiency syndrome	0.00184	0.00184	CcSEcCtD
Gadoteridol—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.00184	0.00184	CcSEcCtD
Gadoteridol—Chest pain—Efavirenz—acquired immunodeficiency syndrome	0.00184	0.00184	CcSEcCtD
Gadoteridol—Rash—Amprenavir—acquired immunodeficiency syndrome	0.00184	0.00184	CcSEcCtD
Gadoteridol—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.00184	0.00184	CcSEcCtD
Gadoteridol—Shock—Indinavir—acquired immunodeficiency syndrome	0.00184	0.00184	CcSEcCtD
Gadoteridol—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.00183	0.00183	CcSEcCtD
Gadoteridol—Anxiety—Efavirenz—acquired immunodeficiency syndrome	0.00183	0.00183	CcSEcCtD
Gadoteridol—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.00183	0.00183	CcSEcCtD
Gadoteridol—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.00183	0.00183	CcSEcCtD
Gadoteridol—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00183	0.00183	CcSEcCtD
Gadoteridol—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.00183	0.00183	CcSEcCtD
Gadoteridol—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.00183	0.00183	CcSEcCtD
Gadoteridol—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.00182	0.00182	CcSEcCtD
Gadoteridol—Discomfort—Efavirenz—acquired immunodeficiency syndrome	0.00182	0.00182	CcSEcCtD
Gadoteridol—Loss of consciousness—Delavirdine—acquired immunodeficiency syndrome	0.00182	0.00182	CcSEcCtD
Gadoteridol—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.00181	0.00181	CcSEcCtD
Gadoteridol—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.0018	0.0018	CcSEcCtD
Gadoteridol—Cough—Delavirdine—acquired immunodeficiency syndrome	0.0018	0.0018	CcSEcCtD
Gadoteridol—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.0018	0.0018	CcSEcCtD
Gadoteridol—Dysgeusia—Saquinavir—acquired immunodeficiency syndrome	0.0018	0.0018	CcSEcCtD
Gadoteridol—Dry mouth—Efavirenz—acquired immunodeficiency syndrome	0.0018	0.0018	CcSEcCtD
Gadoteridol—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.0018	0.0018	CcSEcCtD
Gadoteridol—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.0018	0.0018	CcSEcCtD
Gadoteridol—Tremor—Ritonavir—acquired immunodeficiency syndrome	0.00179	0.00179	CcSEcCtD
Gadoteridol—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.00179	0.00179	CcSEcCtD
Gadoteridol—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.00179	0.00179	CcSEcCtD
Gadoteridol—Ill-defined disorder—Ritonavir—acquired immunodeficiency syndrome	0.00177	0.00177	CcSEcCtD
Gadoteridol—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.00176	0.00176	CcSEcCtD
Gadoteridol—Chest pain—Delavirdine—acquired immunodeficiency syndrome	0.00176	0.00176	CcSEcCtD
Gadoteridol—Erythema—Lamivudine—acquired immunodeficiency syndrome	0.00176	0.00176	CcSEcCtD
Gadoteridol—Anxiety—Delavirdine—acquired immunodeficiency syndrome	0.00175	0.00175	CcSEcCtD
Gadoteridol—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.00174	0.00174	CcSEcCtD
Gadoteridol—Shock—Efavirenz—acquired immunodeficiency syndrome	0.00174	0.00174	CcSEcCtD
Gadoteridol—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00173	0.00173	CcSEcCtD
Gadoteridol—Malaise—Ritonavir—acquired immunodeficiency syndrome	0.00172	0.00172	CcSEcCtD
Gadoteridol—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.00172	0.00172	CcSEcCtD
Gadoteridol—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.00172	0.00172	CcSEcCtD
Gadoteridol—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.00172	0.00172	CcSEcCtD
Gadoteridol—Pain—Zidovudine—acquired immunodeficiency syndrome	0.00172	0.00172	CcSEcCtD
Gadoteridol—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.00172	0.00172	CcSEcCtD
Gadoteridol—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.00171	0.00171	CcSEcCtD
Gadoteridol—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.00171	0.00171	CcSEcCtD
Gadoteridol—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.00171	0.00171	CcSEcCtD
Gadoteridol—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.0017	0.0017	CcSEcCtD
Gadoteridol—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.00169	0.00169	CcSEcCtD
Gadoteridol—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.00169	0.00169	CcSEcCtD
Gadoteridol—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.00169	0.00169	CcSEcCtD
Gadoteridol—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.00168	0.00168	CcSEcCtD
Gadoteridol—Rash—Didanosine—acquired immunodeficiency syndrome	0.00168	0.00168	CcSEcCtD
Gadoteridol—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.00168	0.00168	CcSEcCtD
Gadoteridol—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.00168	0.00168	CcSEcCtD
Gadoteridol—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00168	0.00168	CcSEcCtD
Gadoteridol—Cough—Ritonavir—acquired immunodeficiency syndrome	0.00167	0.00167	CcSEcCtD
Gadoteridol—Headache—Didanosine—acquired immunodeficiency syndrome	0.00167	0.00167	CcSEcCtD
Gadoteridol—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.00166	0.00166	CcSEcCtD
Gadoteridol—Shock—Delavirdine—acquired immunodeficiency syndrome	0.00166	0.00166	CcSEcCtD
Gadoteridol—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.00166	0.00166	CcSEcCtD
Gadoteridol—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.00166	0.00166	CcSEcCtD
Gadoteridol—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.00165	0.00165	CcSEcCtD
Gadoteridol—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.00165	0.00165	CcSEcCtD
Gadoteridol—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.00165	0.00165	CcSEcCtD
Gadoteridol—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.00165	0.00165	CcSEcCtD
Gadoteridol—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.00164	0.00164	CcSEcCtD
Gadoteridol—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00164	0.00164	CcSEcCtD
Gadoteridol—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.00163	0.00163	CcSEcCtD
Gadoteridol—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.00163	0.00163	CcSEcCtD
Gadoteridol—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.00163	0.00163	CcSEcCtD
Gadoteridol—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.00163	0.00163	CcSEcCtD
Gadoteridol—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.00162	0.00162	CcSEcCtD
Gadoteridol—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.00162	0.00162	CcSEcCtD
Gadoteridol—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00161	0.00161	CcSEcCtD
Gadoteridol—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00161	0.00161	CcSEcCtD
Gadoteridol—Cough—Saquinavir—acquired immunodeficiency syndrome	0.00161	0.00161	CcSEcCtD
Gadoteridol—Pain—Indinavir—acquired immunodeficiency syndrome	0.0016	0.0016	CcSEcCtD
Gadoteridol—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.00159	0.00159	CcSEcCtD
Gadoteridol—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.00159	0.00159	CcSEcCtD
Gadoteridol—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.00159	0.00159	CcSEcCtD
Gadoteridol—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.00159	0.00159	CcSEcCtD
Gadoteridol—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.00159	0.00159	CcSEcCtD
Gadoteridol—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.00159	0.00159	CcSEcCtD
Gadoteridol—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.00159	0.00159	CcSEcCtD
Gadoteridol—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.00158	0.00158	CcSEcCtD
Gadoteridol—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.00158	0.00158	CcSEcCtD
Gadoteridol—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.00158	0.00158	CcSEcCtD
Gadoteridol—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00158	0.00158	CcSEcCtD
Gadoteridol—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.00158	0.00158	CcSEcCtD
Gadoteridol—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.00157	0.00157	CcSEcCtD
Gadoteridol—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.00157	0.00157	CcSEcCtD
Gadoteridol—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.00157	0.00157	CcSEcCtD
Gadoteridol—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.00156	0.00156	CcSEcCtD
Gadoteridol—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.00156	0.00156	CcSEcCtD
Gadoteridol—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.00156	0.00156	CcSEcCtD
Gadoteridol—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.00155	0.00155	CcSEcCtD
Gadoteridol—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.00154	0.00154	CcSEcCtD
Gadoteridol—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.00154	0.00154	CcSEcCtD
Gadoteridol—Shock—Ritonavir—acquired immunodeficiency syndrome	0.00154	0.00154	CcSEcCtD
Gadoteridol—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.00153	0.00153	CcSEcCtD
Gadoteridol—Cough—Lamivudine—acquired immunodeficiency syndrome	0.00153	0.00153	CcSEcCtD
Gadoteridol—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.00153	0.00153	CcSEcCtD
Gadoteridol—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.00153	0.00153	CcSEcCtD
Gadoteridol—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.00152	0.00152	CcSEcCtD
Gadoteridol—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00152	0.00152	CcSEcCtD
Gadoteridol—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.00152	0.00152	CcSEcCtD
Gadoteridol—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.00151	0.00151	CcSEcCtD
Gadoteridol—Pain—Efavirenz—acquired immunodeficiency syndrome	0.00151	0.00151	CcSEcCtD
Gadoteridol—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00151	0.00151	CcSEcCtD
Gadoteridol—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00151	0.00151	CcSEcCtD
Gadoteridol—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.0015	0.0015	CcSEcCtD
Gadoteridol—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.0015	0.0015	CcSEcCtD
Gadoteridol—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.0015	0.0015	CcSEcCtD
Gadoteridol—Headache—Nevirapine—acquired immunodeficiency syndrome	0.0015	0.0015	CcSEcCtD
Gadoteridol—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.00149	0.00149	CcSEcCtD
Gadoteridol—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.00149	0.00149	CcSEcCtD
Gadoteridol—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.00148	0.00148	CcSEcCtD
Gadoteridol—Shock—Saquinavir—acquired immunodeficiency syndrome	0.00148	0.00148	CcSEcCtD
Gadoteridol—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.00148	0.00148	CcSEcCtD
Gadoteridol—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.00148	0.00148	CcSEcCtD
Gadoteridol—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.00148	0.00148	CcSEcCtD
Gadoteridol—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00147	0.00147	CcSEcCtD
Gadoteridol—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.00147	0.00147	CcSEcCtD
Gadoteridol—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.00146	0.00146	CcSEcCtD
Gadoteridol—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.00146	0.00146	CcSEcCtD
Gadoteridol—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.00146	0.00146	CcSEcCtD
Gadoteridol—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.00146	0.00146	CcSEcCtD
Gadoteridol—Rash—Stavudine—acquired immunodeficiency syndrome	0.00146	0.00146	CcSEcCtD
Gadoteridol—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.00146	0.00146	CcSEcCtD
Gadoteridol—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.00145	0.00145	CcSEcCtD
Gadoteridol—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.00145	0.00145	CcSEcCtD
Gadoteridol—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.00145	0.00145	CcSEcCtD
Gadoteridol—Headache—Stavudine—acquired immunodeficiency syndrome	0.00145	0.00145	CcSEcCtD
Gadoteridol—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.00145	0.00145	CcSEcCtD
Gadoteridol—Pain—Delavirdine—acquired immunodeficiency syndrome	0.00144	0.00144	CcSEcCtD
Gadoteridol—Rash—Abacavir—acquired immunodeficiency syndrome	0.00143	0.00143	CcSEcCtD
Gadoteridol—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.00143	0.00143	CcSEcCtD
Gadoteridol—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.00143	0.00143	CcSEcCtD
Gadoteridol—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.00143	0.00143	CcSEcCtD
Gadoteridol—Headache—Abacavir—acquired immunodeficiency syndrome	0.00143	0.00143	CcSEcCtD
Gadoteridol—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00142	0.00142	CcSEcCtD
Gadoteridol—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.00142	0.00142	CcSEcCtD
Gadoteridol—Shock—Lamivudine—acquired immunodeficiency syndrome	0.00141	0.00141	CcSEcCtD
Gadoteridol—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.0014	0.0014	CcSEcCtD
Gadoteridol—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.0014	0.0014	CcSEcCtD
Gadoteridol—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.0014	0.0014	CcSEcCtD
Gadoteridol—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.00139	0.00139	CcSEcCtD
Gadoteridol—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.00139	0.00139	CcSEcCtD
Gadoteridol—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.00139	0.00139	CcSEcCtD
Gadoteridol—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.00139	0.00139	CcSEcCtD
Gadoteridol—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.00139	0.00139	CcSEcCtD
Gadoteridol—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00138	0.00138	CcSEcCtD
Gadoteridol—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.00138	0.00138	CcSEcCtD
Gadoteridol—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.00137	0.00137	CcSEcCtD
Gadoteridol—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00137	0.00137	CcSEcCtD
Gadoteridol—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00135	0.00135	CcSEcCtD
Gadoteridol—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.00135	0.00135	CcSEcCtD
Gadoteridol—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.00134	0.00134	CcSEcCtD
Gadoteridol—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.00134	0.00134	CcSEcCtD
Gadoteridol—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.00134	0.00134	CcSEcCtD
Gadoteridol—Pain—Ritonavir—acquired immunodeficiency syndrome	0.00133	0.00133	CcSEcCtD
Gadoteridol—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.00133	0.00133	CcSEcCtD
Gadoteridol—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.00133	0.00133	CcSEcCtD
Gadoteridol—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.00133	0.00133	CcSEcCtD
Gadoteridol—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.00132	0.00132	CcSEcCtD
Gadoteridol—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.0013	0.0013	CcSEcCtD
Gadoteridol—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.00129	0.00129	CcSEcCtD
Gadoteridol—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.00129	0.00129	CcSEcCtD
Gadoteridol—Pain—Saquinavir—acquired immunodeficiency syndrome	0.00128	0.00128	CcSEcCtD
Gadoteridol—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.00128	0.00128	CcSEcCtD
Gadoteridol—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.00128	0.00128	CcSEcCtD
Gadoteridol—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.00128	0.00128	CcSEcCtD
Gadoteridol—Rash—Zidovudine—acquired immunodeficiency syndrome	0.00127	0.00127	CcSEcCtD
Gadoteridol—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.00126	0.00126	CcSEcCtD
Gadoteridol—Headache—Zidovudine—acquired immunodeficiency syndrome	0.00126	0.00126	CcSEcCtD
Gadoteridol—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.00125	0.00125	CcSEcCtD
Gadoteridol—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.00124	0.00124	CcSEcCtD
Gadoteridol—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.00124	0.00124	CcSEcCtD
Gadoteridol—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.00124	0.00124	CcSEcCtD
Gadoteridol—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.00123	0.00123	CcSEcCtD
Gadoteridol—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.00123	0.00123	CcSEcCtD
Gadoteridol—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.00123	0.00123	CcSEcCtD
Gadoteridol—Pain—Lamivudine—acquired immunodeficiency syndrome	0.00123	0.00123	CcSEcCtD
Gadoteridol—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.00121	0.00121	CcSEcCtD
Gadoteridol—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.00119	0.00119	CcSEcCtD
Gadoteridol—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.00119	0.00119	CcSEcCtD
Gadoteridol—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00119	0.00119	CcSEcCtD
Gadoteridol—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.00119	0.00119	CcSEcCtD
Gadoteridol—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.00119	0.00119	CcSEcCtD
Gadoteridol—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.00119	0.00119	CcSEcCtD
Gadoteridol—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.00118	0.00118	CcSEcCtD
Gadoteridol—Rash—Indinavir—acquired immunodeficiency syndrome	0.00118	0.00118	CcSEcCtD
Gadoteridol—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.00118	0.00118	CcSEcCtD
Gadoteridol—Headache—Indinavir—acquired immunodeficiency syndrome	0.00117	0.00117	CcSEcCtD
Gadoteridol—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.00117	0.00117	CcSEcCtD
Gadoteridol—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.00115	0.00115	CcSEcCtD
Gadoteridol—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.00115	0.00115	CcSEcCtD
Gadoteridol—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.00114	0.00114	CcSEcCtD
Gadoteridol—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.00113	0.00113	CcSEcCtD
Gadoteridol—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.00113	0.00113	CcSEcCtD
Gadoteridol—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.00112	0.00112	CcSEcCtD
Gadoteridol—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.00112	0.00112	CcSEcCtD
Gadoteridol—Rash—Efavirenz—acquired immunodeficiency syndrome	0.00111	0.00111	CcSEcCtD
Gadoteridol—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.00111	0.00111	CcSEcCtD
Gadoteridol—Nausea—Indinavir—acquired immunodeficiency syndrome	0.00111	0.00111	CcSEcCtD
Gadoteridol—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.00111	0.00111	CcSEcCtD
Gadoteridol—Headache—Efavirenz—acquired immunodeficiency syndrome	0.00111	0.00111	CcSEcCtD
Gadoteridol—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.0011	0.0011	CcSEcCtD
Gadoteridol—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.00107	0.00107	CcSEcCtD
Gadoteridol—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.00107	0.00107	CcSEcCtD
Gadoteridol—Rash—Delavirdine—acquired immunodeficiency syndrome	0.00106	0.00106	CcSEcCtD
Gadoteridol—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.00106	0.00106	CcSEcCtD
Gadoteridol—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.00106	0.00106	CcSEcCtD
Gadoteridol—Headache—Delavirdine—acquired immunodeficiency syndrome	0.00106	0.00106	CcSEcCtD
Gadoteridol—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.00106	0.00106	CcSEcCtD
Gadoteridol—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.00105	0.00105	CcSEcCtD
Gadoteridol—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.00103	0.00103	CcSEcCtD
Gadoteridol—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.00103	0.00103	CcSEcCtD
Gadoteridol—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.00101	0.00101	CcSEcCtD
Gadoteridol—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.001	0.001	CcSEcCtD
Gadoteridol—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000993	0.000993	CcSEcCtD
Gadoteridol—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000992	0.000992	CcSEcCtD
Gadoteridol—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000984	0.000984	CcSEcCtD
Gadoteridol—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000983	0.000983	CcSEcCtD
Gadoteridol—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000981	0.000981	CcSEcCtD
Gadoteridol—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000978	0.000978	CcSEcCtD
Gadoteridol—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000955	0.000955	CcSEcCtD
Gadoteridol—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000948	0.000948	CcSEcCtD
Gadoteridol—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000947	0.000947	CcSEcCtD
Gadoteridol—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000946	0.000946	CcSEcCtD
Gadoteridol—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000941	0.000941	CcSEcCtD
Gadoteridol—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000927	0.000927	CcSEcCtD
Gadoteridol—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000911	0.000911	CcSEcCtD
Gadoteridol—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000904	0.000904	CcSEcCtD
Gadoteridol—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000903	0.000903	CcSEcCtD
Gadoteridol—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000898	0.000898	CcSEcCtD
Gadoteridol—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000892	0.000892	CcSEcCtD
Gadoteridol—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000851	0.000851	CcSEcCtD
